These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 17261034
21. Application of genetic algorithm-support vector machine (GA-SVM) for prediction of BK-channels activity. Pourbasheer E, Riahi S, Ganjali MR, Norouzi P. Eur J Med Chem; 2009 Dec; 44(12):5023-8. PubMed ID: 19837488 [Abstract] [Full Text] [Related]
24. ADMET Evaluation in Drug Discovery. 16. Predicting hERG Blockers by Combining Multiple Pharmacophores and Machine Learning Approaches. Wang S, Sun H, Liu H, Li D, Li Y, Hou T. Mol Pharm; 2016 Aug 01; 13(8):2855-66. PubMed ID: 27379394 [Abstract] [Full Text] [Related]
26. Computer simulations of structure-activity relationships for HERG channel blockers. Boukharta L, Keränen H, Stary-Weinzinger A, Wallin G, de Groot BL, Aqvist J. Biochemistry; 2011 Jul 12; 50(27):6146-56. PubMed ID: 21657256 [Abstract] [Full Text] [Related]
27. Prediction of P-glycoprotein substrates by a support vector machine approach. Xue Y, Yap CW, Sun LZ, Cao ZW, Wang JF, Chen YZ. J Chem Inf Comput Sci; 2004 Jul 12; 44(4):1497-505. PubMed ID: 15272858 [Abstract] [Full Text] [Related]
30. A novel QSAR model for prediction of apoptosis-inducing activity of 4-aryl-4-H-chromenes based on support vector machine. Fatemi MH, Gharaghani S. Bioorg Med Chem; 2007 Dec 15; 15(24):7746-54. PubMed ID: 17870538 [Abstract] [Full Text] [Related]
31. Support vector machine-based quantitative structure-activity relationship study of cholesteryl ester transfer protein inhibitors. Riahi S, Pourbasheer E, Ganjali MR, Norouzi P. Chem Biol Drug Des; 2009 May 15; 73(5):558-71. PubMed ID: 19323654 [Abstract] [Full Text] [Related]
32. QSAR modeling of human serum protein binding with several modeling techniques utilizing structure-information representation. Votano JR, Parham M, Hall LM, Hall LH, Kier LB, Oloff S, Tropsha A. J Med Chem; 2006 Nov 30; 49(24):7169-81. PubMed ID: 17125269 [Abstract] [Full Text] [Related]
33. Prediction of intrinsic solubility of generic drugs using MLR, ANN and SVM analyses. Louis B, Agrawal VK, Khadikar PV. Eur J Med Chem; 2010 Sep 30; 45(9):4018-25. PubMed ID: 20584562 [Abstract] [Full Text] [Related]
34. Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockers. Aronov AM. J Med Chem; 2006 Nov 16; 49(23):6917-21. PubMed ID: 17154521 [Abstract] [Full Text] [Related]
35. Exploring QSTR and toxicophore of hERG K+ channel blockers using GFA and HypoGen techniques. Garg D, Gandhi T, Gopi Mohan C. J Mol Graph Model; 2008 Feb 16; 26(6):966-76. PubMed ID: 17928249 [Abstract] [Full Text] [Related]
39. Predictive QSAR models development and validation for human ether-a-go-go related gene (hERG) blockers using newer tools. Moorthy NS, Ramos MJ, Fernandes PA. J Enzyme Inhib Med Chem; 2014 Jun 16; 29(3):317-24. PubMed ID: 23560722 [Abstract] [Full Text] [Related]
40. Drug discovery using support vector machines. The case studies of drug-likeness, agrochemical-likeness, and enzyme inhibition predictions. Zernov VV, Balakin KV, Ivaschenko AA, Savchuk NP, Pletnev IV. J Chem Inf Comput Sci; 2003 Jun 16; 43(6):2048-56. PubMed ID: 14632457 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]